Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01 Clinical Trial Not Allowed)
Department of Health and Human Services National Institutes of Health
Posted on:
Bewerbungsschluss:
Expired
Typ
Research/project funding
Reference Number
RFA-AI-22-016
The purpose of this Funding Opportunity Announcement (FOA) is to support the development of new diagnostic technologies for tuberculosis (TB) drug susceptibility testing (DST), including point of care (POC) DST and companion diagnostics for new TB drugs.
Categories: Health.
Categories: Health.
USA